REYNDERS PHARMACEUTICAL LABELS
The computed 12-month bankruptcy probability of REYNDERS PHARMACEUTICAL LABELS is 0.3% (very low). The company has been active since 1991 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 35 yrs |
| Board | 8 |
| Locations | 1 |
| Publications | 32 |
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | volledig | 19-05-2026 | 2026-00117908 |
| 31-12-2024 | volledig | 23-04-2025 | 2025-00075624 |
| 31-12-2023 | volledig | 22-04-2024 | 2024-00066542 |
| 31-12-2022 | volledig | 05-07-2023 | 2023-00208978 |
| 31-12-2021 | volledig | 15-06-2022 | 2022-20063687 |
| 31-12-2020 | volledig | 14-06-2021 | 2021-19700314 |
| 31-12-2019 | volledig | 30-06-2020 | 2020-24400235 |
| 31-12-2018 | volledig | 14-06-2019 | 2019-19800550 |
| 31-12-2017 | volledig | 25-06-2018 | 2018-22900493 |
| 31-12-2016 | volledig | 14-06-2017 | 2017-17600268 |
-
Lintacker Consulting BVLegal entityDirector· perm. rep.: Jacques ReyndersState Gazette act 26074749 (11-06-2026)Current20-04-2026 → present
-
Lintacker ConsultingLegal entityDirector· perm. rep.: Jacques ReyndersState Gazette act 20081540 (17-07-2020)Current17-07-2020 → present
-
MRS ConsultingLegal entityDirector· perm. rep.: Sebastiaan ReyndersState Gazette act 20081540 (17-07-2020)Current17-07-2020 → present
-
Reynesco InvestLegal entityDirector· perm. rep.: Marc ReyndersState Gazette act 20081540 (17-07-2020)Current17-07-2020 → present
-
VeldkantLegal entityDirector· perm. rep.: Paul ReyndersState Gazette act 20081540 (17-07-2020)Current17-07-2020 → present
-
MRS Consulting BVBALegal entityDirector· perm. rep.: Sebastiaan ReyndersState Gazette act 20027096 (18-02-2020)Current30-12-2019 → present
-
Reynesco Invest NVLegal entityDirector· perm. rep.: Marc ReyndersState Gazette act 26074749 (11-06-2026)Current30-12-2019 → present
2 events
- 20-04-2026 Mandate renewed· Director
- 30-12-2019 Appointed· Director
-
VELDKANTLegal entityManaging director· perm. rep.: Paul ReyndersState Gazette act 20027096 (18-02-2020)Current03-07-2017 → present
2 events
- 30-12-2019 Appointed· Managing director
- 03-07-2017 Appointed· Director
Former directors (6)
-
Veldkant NVLegal entityManaging director· perm. rep.: Paul ReyndersState Gazette act 23120158 (19-09-2023)Former— → 19-09-2023
-
MRS CONSULTINGLegal entityDirector· perm. rep.: Sebastiaan ReyndersState Gazette act 21123678 (18-10-2021)Former— → 01-10-2021
-
Former— → 30-12-2019
-
Former— → 30-12-2019
-
Former— → 30-12-2019
-
Former— → 03-07-2017
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Ernst & Young & Partners BCVBACurrent Statutory auditor · represented by Robert Boons |
— | 18-10-2016 → present |
| Ernst & Young Bedrijfsrevisoren BVCurrent Statutory auditor · represented by Koen De Nijs |
— | 19-09-2023 → present |
| Ernst & Young Bedrijfsrevisoren CVBACurrent Statutory auditor · represented by Ronald Van den Ecker |
— | 01-07-2019 → present |
| EY Bedrijfsrevisoren BVCurrent Statutory auditor · represented by Koen De Nijs |
— | 22-04-2025 → present |
| Ronald Van den EckerCurrent Statutory auditor |
— | 01-07-2017 → present |
| NACE primary | 18120 |
| Legal form | Public limited company(014) |
| Incorporation | 15-01-1991 |
| Status | Active |
| Postal code | 2530 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11004A0032/00F002 | Flanders | 4,387 m² | 1 · 3,200 m² | 9.0 m · 2 fl. |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
11-06-2026 2 directors appointed
- Reynesco Invest NV — Bestuurder
- Lintacker Consulting BV — Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Reynesco Invest NV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Lintacker Consulting BV",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "Reynders Pharmaceutical Labels"
}
}11-06-2026 2 reappointed
- Marc Reynders — Bestuurder
- Jacques Reynders — Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc Reynders",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Reynesco Invest NV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2026-04-20",
"evidence_quote": "De algemene vergadering beslist als bestuurder te herbenoemen: Reynesco Invest NV, Nijverheidsstraat 3, 2530 Boechout. Haar mandaat gaat in op 20/04/2026 en heeft een bepaalde duur en zal dus behoudens herverkiezing eindigen op 20/04/2032. Voor deze vennootschap zal Marc Reynders wonende te Bloemenh"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jacques Reynders",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Lintacker Consulting BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2026-04-20",
"evidence_quote": "De algemene vergadering beslist als bestuurder te herbenoemen: Lintacker Consulting BV, Hof Van Boechout 1, 2530 Boechout. Haar mandaat gaat in op 20/04/2026 en heeft een bepaalde duur en zai dus behoudens herverkiezing eindigen op 20/04/2032. Voor deze vennootschap zal Jacques Reynders wonende te H"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "NV"
}
}11-06-2026 Publication in the Belgian Official Gazette — Minor change
Technical details
{
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Luik",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-06-11",
"filing_date": "2026-06-03",
"act_kind_objet": "na neerlegging van de akte ter griffie"
},
"decision": {
"body": "algemene_vergadering",
"date": "2026-04-20",
"unanimous": null
},
"agm_change": null,
"detected_kind": "officer_designation",
"other_address": null,
"mandate_renewal": {
"period_end": "2032-04-20",
"mandate_kind": "bestuurder",
"period_start": "2026-04-20",
"remuneration_eur": null,
"remuneration_kind": "gratuit",
"person_or_entity_kbo": null,
"person_or_entity_name": "Reynesco Invest NV"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "Reynders Pharmaceutical Labels",
"legal_form": "naamloze vennootschap"
},
"accounts_deposit": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Marc Reynders",
"org_rep_person_name": null
},
"co_filed_documents": [],
"fiscal_year_change": null,
"liquidation_closure": null,
"officer_designation": {
"role": "bestuurder",
"organ": "raad_van_bestuur",
"person_name": "Reynesco Invest NV"
},
"special_procuration": null,
"is_volet_a_only_stub": false,
"vakbekwaamheid_change": null,
"should_reroute_to_category": null,
"single_shareholder_declaration": null
}07-07-2025 4 directors appointed
- EY Bedrijfsrevisoren BV — Commissaris
- Nadine Crocaerts — Gedelegeerd bestuurder
- Anton Baeten — Gedelegeerd bestuurder
- Stephanie Struyfs — Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "EY Bedrijfsrevisoren BV",
"address": "Borsbeeksebrug 26, 2600 Berchem",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De aigemene vergadering stelt aan EY Bedrijfsrevisoren BV als commissaris van de vennootschap, met zetei te Borsbeeksebrug 26, 2600 Berchem, die zal vertegenwoordigd worden door Koen De Nijs.",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2028"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Nadine Crocaerts",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "BDO Advisory BV",
"address": "1050 Elsene, De Stassartstraat 35",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De aandeelhouders beslissen tenslotte om mevrouw Nadine Crocaerts en/of de heer Anton Baeten, die allen keuze van woonplaats doen bij BDO Advisory BV te 1050 Elsene, De Stassartstraat 35, ... aan te stellen als bijzonder gevolmachtigden, elk met de bevoegdheid om alleen te handelen en met recht van ",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Anton Baeten",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "BDO Advisory BV",
"address": "1050 Elsene, De Stassartstraat 35",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De aandeelhouders beslissen tenslotte om mevrouw Nadine Crocaerts en/of de heer Anton Baeten, die allen keuze van woonplaats doen bij BDO Advisory BV te 1050 Elsene, De Stassartstraat 35, ... aan te stellen als bijzonder gevolmachtigden, elk met de bevoegdheid om alleen te handelen en met recht van ",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Stephanie Struyfs",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "BDO Belgium BV",
"address": "1930 Zaventem, Da Vincilaan 9 Box E.6, The Corporate Village - Elsinore Building",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De aandeelhouders beslissen tenslotte om mevrouw Nadine Crocaerts en/of de heer Anton Baeten, die allen keuze van woonplaats doen bij BDO Advisory BV te 1050 Elsene, De Stassartstraat 35, en/of mevrouw Stephanie Struyfs, die keuze van woonplaats doet bij BDO Belgium BV te 1930 Zaventem, Da Vincilaan",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "publication_proxy",
"role": "Bijzonder gevolmachtigde",
"person": {
"rrn": null,
"name": "Stephanie Struyfs",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Voor eensluidend uittreksel Stephanie Struyfs Bijzonder gevolmachtigde",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-07-07",
"filing_date": "2025-04-22",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-04-22",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0443.025.922",
"name_full": "Reynders Pharmaceutical Labels",
"legal_form": "naamloze vennootschap",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stephanie Struyfs",
"org_rep_person_name": null,
"person_role_at_subject": "Bijzonder gevolmachtigde"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}07-07-2025 EY Bedrijfsrevisoren BV appointed as statutory auditor
- EY Bedrijfsrevisoren BV — Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "EY Bedrijfsrevisoren BV",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "Reynders Pharmaceutical Labels"
}
}07-07-2025 Koen De Nijs reappointed as statutory auditor
- Koen De Nijs — Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Koen De Nijs",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "EY Bedrijfsrevisoren BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-04-22",
"evidence_quote": "De aigemene vergadering stelt aan EY Bedrijfsrevisoren BV als commissaris van de vennootschap, met zetei te Borsbeeksebrug 26, 2600 Berchem, die zal vertegenwoordigd worden door Koen De Nijs. bedrijfsrevisor."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "NV"
}
}04-01-2024 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": true
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS"
},
"legal_form_change": {
"new": "",
"old": "",
"changed": false
}
}04-01-2024 Publication in the Belgian Official Gazette — Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Stephane Van Roosbroeck",
"firm_city": null,
"firm_name": null,
"office_city": "Boechout",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-01-04",
"filing_date": "2024-01-02",
"act_kind_objet": "ALGEMENE VERGADERING, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), DOEL, DIVERSEN"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-12-12",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0443.025.922",
"name": "REYNDERS PHARMACEUTICAL LABELS",
"role": "other",
"address": "Nijverheidsstraat 15, 2530 Boechout",
"is_foreign": false,
"legal_form": "Naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null
},
"summary_narrative": "De buitengewone algemene vergadering van REYNDERS PHARMACEUTICAL LABELS heeft een reeks besluiten genomen om de statuten te wijzigen. Dit omvat het schrappen van aandelensoorten, het herformuleren van het voorwerp van de vennootschap, het wijzigen van de datum van de jaarvergadering en het aanvaarden van volledig nieuwe statuten die in overeenstemming zijn met de wetgeving.",
"co_filed_documents": [
"afschrift pv",
"geco\u00F6rdineerde statuten"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}04-01-2024 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": true,
"effective_date": "2023-12-12",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "NV"
},
"signature_regime": "joint_two",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}04-01-2024 Publication in the Belgian Official Gazette — Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Stephane Van Roosbroeck",
"firm_city": null,
"firm_name": null,
"office_city": "Boechout",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-01-04",
"filing_date": "2024-01-02",
"act_kind_objet": "ALGEMENE VERGADERING, STATUTEN (VERTALING,"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2023-12-12",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": null,
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stephane Van Roosbroeck",
"org_rep_person_name": null
},
"summary_narrative": "De algemene vergadering van aandeelhouders van REYNDERS PHARMACEUTICAL LABELS besloot de statuten te wijzigen, onder meer door de afschaffing van aandelensoorten, het schrappen van het minimum aantal bestuurders en het herformuleren van het bedrijfsdoel. De nieuwe statuten werden aangenomen en zijn in overeenstemming met het Wetboek van Vennootschappen en Verenigingen.",
"co_filed_documents": [
"geco\u00F6rdineerde statuten"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}19-09-2023 6 directors appointed, 1 resigning
- Leen Lefevere — Bestuurder
- Julie Vandenweghe — Bestuurder
- Timon Sohier — Bestuurder
- Annick Delmaire — Bestuurder
- Ernst & Young Bedrijfsrevisoren BV — Commissaris
- Koen De Nijs — Vertegenwoordiger commissaris
- Paul Reynders — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Reynders",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Leen Lefevere",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Julie Vandenweghe",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Timon Sohier",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Annick Delmaire",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Ernst \u0026 Young Bedrijfsrevisoren BV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vertegenwoordiger commissaris",
"person": {
"rrn": null,
"name": "Koen De Nijs",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS"
}
}19-09-2023 1 resigning, 1 reappointed
- Paul Reynders — Gedelegeerd bestuurder
- Koen De Nijs — Commissaris
Technical details
{
"events": [
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Paul Reynders",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Veldkant NV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-09-19",
"evidence_quote": "De bestuurders nemen kennis van haar ontslag van gedelegeerd bestuurder Veldkant NV (vast vertegenwoordigd door de heer Paul Reynders) met ingang van heden.",
"discharge_granted": false
},
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Koen De Nijs",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Ernst \u0026 Young Bedrijfsrevisoren BV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De vergadering bevestigt, voor zover noodzakelijk, de herbenoeming van de commissaris Ernst \u0026 Young Bedrijfsrevisoren BV vanaf de controle over het boekjaar 2022."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "NV"
}
}18-10-2021 Sebastiaan Reynders resigns as director
- Sebastiaan Reynders — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sebastiaan Reynders",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0861171146",
"name": "MRS Consulting BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2021-10-01",
"evidence_quote": "De aandeelhouders bevestigen er bekrachtigen het ontslag uit de functie van bestuurder per 1 oktober 2021 van MRS Consulting BV (0861.171.146) met als vaste vertegerwoordiger de heer Sebastiaan Reynders."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "NV"
}
}18-10-2021 Sebastiaan Reynders resigns as director
- Sebastiaan Reynders — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sebastiaan Reynders",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "Reynders Pharmaceutical Labels"
}
}17-07-2020 1 resigning, 4 reappointed
- Ernst & Young Bedrijfsrevisoren BV — Commissaris
- Marc Reynders — Bestuurder
- Paul Reynders — Bestuurder
- Sebastiaan Reynders — Bestuurder
- Jacques Reynders — Bestuurder
Technical details
{
"events": [
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Ernst \u0026 Young Bedrijfsrevisoren BV",
"address": null,
"birth_date": null
},
"effective_date": "2020-07-01",
"evidence_quote": "Ingevolge beslissing van Ernst \u0026 Young Bedrijfsrevisoren BV werd besloten om vanaf boekjaar 2019, in de plaats van de heer Ronald Van den Ecker, de heer Koen De Nijs aan te stellen als vaste vertegenwoordiger in het kader van het mandaat van commissaris bij Reynders Pharmaceutical Labels NV dat onmi"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc Reynders",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Reynesco Invest",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De algemene vergadering beslist de huidige bestuurders te herbenoemen voor een periode van 6 jaar tot aan de jaarvergadering in 2026 m.n. : -de naamloze vennootschap Reynesco Invest met als vaste vertegenwoordiger de heer Marc Reynders"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Reynders",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Veldkant",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De algemene vergadering beslist de huidige bestuurders te herbenoemen voor een periode van 6 jaar tot aan de jaarvergadering in 2026 m.n. : -de naamloze vennootschap Veldkant met als vaste vertegenwoordiger de heer Paul Reynders"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sebastiaan Reynders",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "MRS Consulting",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De algemene vergadering beslist de huidige bestuurders te herbenoemen voor een periode van 6 jaar tot aan de jaarvergadering in 2026 m.n. : -de besloten vennootschap MRS Consulting met als vaste vertegenwoordiger de heer Sebastiaan Reynders"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jacques Reynders",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Lintacker Consulting",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De algemene vergadering beslist de huidige bestuurders te herbenoemen voor een periode van 6 jaar tot aan de jaarvergadering in 2026 m.n. : -de besloten vennootschap Lintacker Consulting met als vaste vertegenwoordiger de heer Jacques Reynders"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "NV"
}
}17-07-2020 5 directors appointed, 1 resigning
- Koen De Nijs — Commissaris
- Marc Reynders — Bestuurder
- Paul Reynders — Bestuurder
- Sebastiaan Reynders — Bestuurder
- Jacques Reynders — Bestuurder
- Ronald Van den Ecker — Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Koen De Nijs",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Ronald Van den Ecker",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc Reynders",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Reynders",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sebastiaan Reynders",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jacques Reynders",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "Reynders Pharmaceutical Labels NV"
}
}18-02-2020 3 directors appointed, 3 resigning
- Paul Reynders — Gedelegeerd bestuurder
- Sebastiaan Reynders — Bestuurder
- Marc Reynders — Bestuurder
- Marc Reynders — Bestuurder
- Jacques Reynders — Bestuurder
- Paul Reynders — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc Reynders",
"address": null,
"birth_date": null
},
"effective_date": "2019-12-30",
"evidence_quote": "De aandeelhouders bevestigen het ontslag uit de functle van bestuurder per 30 december 2019 van de heer Marc Reynders, de heer Jacques Reynders en de heer Paul Reynders.",
"discharge_granted": false
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jacques Reynders",
"address": null,
"birth_date": null
},
"effective_date": "2019-12-30",
"evidence_quote": "De aandeelhouders bevestigen het ontslag uit de functle van bestuurder per 30 december 2019 van de heer Marc Reynders, de heer Jacques Reynders en de heer Paul Reynders.",
"discharge_granted": false
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Reynders",
"address": null,
"birth_date": null
},
"effective_date": "2019-12-30",
"evidence_quote": "De aandeelhouders bevestigen het ontslag uit de functle van bestuurder per 30 december 2019 van de heer Marc Reynders, de heer Jacques Reynders en de heer Paul Reynders.",
"discharge_granted": false
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Paul Reynders",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0435084689",
"name": "Veldkant",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2019-12-30",
"evidence_quote": "De raad van bestuur bevestigt de benoeming als gedelegeerd bestuurder van de Vennootschap voor de ganse duur van haar mandaat als bestuurder en dit met ingang van 30 december 2019 van: -de naamloze vennootschap Veldkant (0435.084.689) met als vaste vertegenwoordiger voor de uitoefening van dit manda"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sebastiaan Reynders",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "MRS Consulting BVBA",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2019-12-30",
"evidence_quote": "De heer Sebastiaan Reynders zal bijgevolg met ingang vanaf heden optreden als vaste vertegenwoordiger van MRS Consulting BVBA als bestuurder binnen [...], (iil) de naamloze vennootschap Reynders Pharmaceutical Labels [...]."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc Reynders",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Reynesco Invest NV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2019-12-30",
"evidence_quote": "De heer Marc Reynders zal bijgevolg met ingang vanaf heden optreden als vaste vertegenwoordiger van Reynesco Invest NV als bestuurder en gedelegeerd bestuurder binnen [...], (i) de naamloze vennootschap Reynders Pharmaceutical Labels [...]."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "NV"
}
}18-02-2020 3 directors appointed, 4 resigning
- Paul Reynders — Gedelegeerd bestuurder
- Sebastiaan Reynders — Vaste vertegenwoordiger
- Marc Reynders — Vaste vertegenwoordiger
- Marc Reynders — Bestuurder
- Jacques Reynders — Bestuurder
- Paul Reynders — Bestuurder
- Paul Reynders — Vaste vertegenwoordiger
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc Reynders",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jacques Reynders",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Reynders",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "gedelegeerd bestuurder",
"person": {
"rrn": null,
"name": "Paul Reynders",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "Sebastiaan Reynders",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "Marc Reynders",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "Paul Reynders",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "Reynders Pharmaceutical Labels"
}
}01-07-2019 2 directors appointed
- Ernst & Young Bedrijfsrevisoren CVBA — Commissaris
- Ronald Van den Ecker — Vaste vertegenwoordiger van commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Ernst \u0026 Young Bedrijfsrevisoren CVBA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger van commissaris",
"person": {
"rrn": null,
"name": "Ronald Van den Ecker",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "Reynders Pharmaceuticals Labels"
}
}01-07-2019 Ronald Van den Ecker reappointed as statutory auditor
- Ronald Van den Ecker — Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Ronald Van den Ecker",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Ernst \u0026 Young Bedrijfsrevisoren CVBA",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De vergadering heeft met algemeenheid van stemmen beslist om Ernst \u0026 Young Bedrijfsrevisoren CVBA, Borsbeeksebrug 26, 2600 Antwerpen, te herbenoemen als commissaris voor een periode van 3 jaar tot de algemene vergadering van 2022."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "NV"
}
}13-06-2018 1 director appointed, 1 resigning
- Paul Reynders — Bestuurder
- Paul Reynders — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Reynders",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Reynders",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "Reynders Pharmaceutical Labels"
}
}13-06-2018 1 director appointed, 1 resigning
- Paul Reynders — Bestuurder
- PRS Consult — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "PRS Consult",
"address": null,
"birth_date": null
},
"effective_date": "2017-07-03",
"evidence_quote": "De vergadering bevestigt en bekrachtigt het ontslag uit de functie van bestuurder ingevolge eendagsvereffening per 3 juli 2017 van de BVBA PRS Consult (0861.171.443) vast vertegenwoordigd door de heer Paul Reynders."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Reynders",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0435084689",
"name": "Veldkant",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2017-07-03",
"evidence_quote": "De vergadering bevestigt en bekrachtigt de benoeming als bestuurder per 3 jul\u00ED 2017 van de naamloze vennootschap Veldkant (0435.084.689) met als vaste vertegenwoordiger voor de uitoefening van dit! bestuurdersmandaat in naam en voor rekening van de voornoemde rechtspersoon, de heer Paul Reynders"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "NV"
}
}23-02-2018 1 director appointed, 1 resigning
- Ronald Van den Ecker — Commissaris
- Ernst & Young Bedrijfsrevisoren Burg. CVBA — Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Ernst \u0026 Young Bedrijfsrevisoren Burg. CVBA",
"address": null,
"birth_date": null
},
"effective_date": "2017-07-01",
"evidence_quote": "Ingevolge beslissing van Ernst \u0026 Young Bedrijfsrevisoren Burg. CVBA werd aangenomen om vanaf 1 juli 2017, in de plaats van de heer Robert Boons, de heer Ronald Van den Ecker (lidmaatschapsnummer AO1851) aan te stellen als vaste vertegenwoordiger in het kader van het mandaat van commissaris bij Reynd"
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Ronald Van den Ecker",
"address": null,
"birth_date": null
},
"effective_date": "2017-07-01",
"evidence_quote": "Ingevolge beslissing van Ernst \u0026 Young Bedrijfsrevisoren Burg. CVBA werd aangenomen om vanaf 1 juli 2017, in de plaats van de heer Robert Boons, de heer Ronald Van den Ecker (lidmaatschapsnummer AO1851) aan te stellen als vaste vertegenwoordiger in het kader van het mandaat van commissaris bij Reynd"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "NV"
}
}23-02-2018 1 director appointed, 1 resigning
- Ronald Van den Ecker — Commissaris
- Robert Boons — Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Ronald Van den Ecker",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Robert Boons",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "Reynders Pharmaceutical Labels NV"
}
}18-10-2016 Ernst & Young & Partners BCVBA appointed as statutory auditor
- Ernst & Young & Partners BCVBA — Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Ernst \u0026 Young \u0026 Partners BCVBA",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "Reynders Pharmaceutical Labels",
"_kbo_extracted_mismatch": "0443.025.992"
}
}18-10-2016 Robert Boons reappointed as statutory auditor
- Robert Boons — Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Robert Boons",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Ernst \u0026 Young \u0026 Partners BCVBA",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Uit de notulen van de Algemene Vergadering van 16 mei 2016 blijkt de herbenoeming van de commissaris, Ernst \u0026 Young \u0026 Partners BCVBA met maatschappelijke zetel te 2140 Borgerhout, Joe Englishstraat 52, voor een periode van drie jaar verstrijkend op de algemene vergadering van 2019. De heer Robert Bo"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "NV"
}
}18-01-2012 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "NV"
}
}18-01-2012 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2012-01-06",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0443.025.922",
"name_full": "REYNDERS PHARMACEUTICAL LABELS",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}18-01-2012 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "Reynders Pharmaceutical Labels"
},
"legal_form_change": {
"new": "naamloze vennootschap",
"old": "naamloze vennootschap",
"changed": false
}
}18-01-2012 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0443.025.922",
"name_full": "Reynders Pharmaceutical Labels"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | REYNDERS PHARMACEUTICAL LABELS |